Literature DB >> 23444076

Increased expression of survivin in hepatoblastoma after chemotherapy.

Shuichiro Uehara1, Takaharu Oue, Miyoko Kawatsu, Keigo Nara, Masahiro Fukuzawa.   

Abstract

BACKGROUND: Survivin, an inhibitor of apoptosis, has been reported to be associated with a worse prognosis in some malignancies. However, its expression in hepatoblastoma (HB) remains to be elucidated. We assessed the survivin expression in HB specimens collected before and after chemotherapy to elucidate the impact of survivin on the outcome of HB therapy.
METHODS: HB specimens were collected before and after 2 to 4 cycles of cisplatin-based chemotherapy from 16 patients. The survivin expression level was assessed by immunohistochemical staining and real-time polymerase chain reaction.
RESULTS: Out of 16, 12 HB sections collected before chemotherapy were positive for survivin as determined by immunohistochemical staining. The intensity of survivin expression was found to significantly increase after chemotherapy. Surprisingly, all of the HB specimens obtained after chemotherapy were positive for survivin. The expression of survivin messenger ribonucleic acid from a human HB cell line, Huh-6 was significantly higher when the cells were cultured with cis-diamminedichloroplatinum(II) than when the cells were cultured without the drug.
CONCLUSION: Our results indicate that most of the primary HB tissue specimens express survivin, and its expression increased after chemotherapy, thus suggesting that survivin may concern with the survival of tumor cells, therefore be a candidate for the target of the treatment of HB. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23444076     DOI: 10.1055/s-0033-1333637

Source DB:  PubMed          Journal:  Eur J Pediatr Surg        ISSN: 0939-7248            Impact factor:   2.191


  2 in total

1.  Intravenous siRNA Silencing of Survivin Enhances Activity of Mitomycin C in Human Bladder RT4 Xenografts.

Authors:  Minjian Cui; Jessie L-S Au; M Guillaume Wientjes; Michael A O'Donnell; Kevin R Loughlin; Ze Lu
Journal:  J Urol       Date:  2015-02-11       Impact factor: 7.450

2.  YM155 and chrysin cooperatively suppress survivin expression in SMARCB1/INI1-deficient tumor cells.

Authors:  Yuki Yoshino; Hiroaki Goto; Mieko Ito; Yoshinori Tsurusaki; Junko Takita; Yasuhide Hayashi; Masakatsu Yanagimachi
Journal:  Med Oncol       Date:  2022-09-29       Impact factor: 3.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.